Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study

被引:99
作者
Delaunay, Jacques [1 ]
Recher, Christian [2 ]
Pigneux, Arnaud [3 ]
Witz, Francis [4 ]
Vey, Norbert [5 ]
Blanchet, Odile [6 ]
Lefebvre, Pascale [7 ]
Luquet, Isabelle [7 ]
Guillerme, Isabelle [8 ]
Volteau, Christelle [8 ]
Gyan, Emmanuel [9 ]
Lioure, Bruno [10 ]
Jourdan, Eric [11 ]
Bouscary, Didier [12 ]
Guieze, Romain [13 ]
Randriamalala, Edouard [14 ]
Uribe, Mario E. Ojeda [15 ]
Dreyfus, Francois [16 ]
Lacombe, Catherine [17 ]
Bene, Marie-christine [18 ]
Cahn, Jean-Yves [19 ]
Harousseau, Jean-Luc [20 ]
Ifrah, Norbert [21 ]
机构
[1] Univ Nantes, CHU Nantes, Nantes, France
[2] Univ Toulouse, Hop Purpan, Toulouse, France
[3] CHU Bordeaux, Pessac, France
[4] CHU Nancy, Nancy, France
[5] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[6] Univ Angers, CHU Angers, Angers, France
[7] Univ Hosp, Reims, France
[8] Univ Hosp, Nantes, France
[9] CHRU Tours, Serv Hematol & Therapie Cellulaire, Tours, France
[10] CHU Strasbourg, F-67000 Strasbourg, France
[11] Univ Nimes, CHU Nimes, Nimes, France
[12] Hop Cochin, APHP, Serv Hematol Clin, F-75674 Paris, France
[13] Univ Auvergne, EA3846, Univ Hosp Estaing,INSERM,CIC 501, Serv Therapie Cellulaire & Hematol Clin Adulte, Clermont Ferrand, France
[14] Univ Poitiers, CHU Poitiers, Poitiers, France
[15] Hop E Muller, Hematol & Cell Therapy Unit, Mulhouse, France
[16] Univ Hosp, Paris, France
[17] Inst Cochin Genet Mol, F-75014 Paris, France
[18] Univ Nancy, CHU Nancy, Nancy, France
[19] CHU Grenoble, Grenoble 09, France
[20] Ctr Rene Gauducheau, Nantes Atantique, Saint Herblain, France
[21] CHU Angers, Serv Hematol, Angers, France
关键词
D O I
10.1182/blood.V118.21.79.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:37 / 38
页数:2
相关论文
empty
未找到相关数据